All News
Why Becoming a Doctor Still Matters
(MedPage Today) -- Like many of the almost 100,000 medical students in the U.S., I enrolled in medical school having grown up infatuated with the idea of becoming a physician.
Read More‘Things could fall over’: businesses and public services on Starmer’s immigration crackdown
Social care, hospitality, health, universities and construction sectors raise questions over impact of planKeir Starmer’s blueprint for curbing immigration could exacerbate skills shortages in secto
Read MoreTrump Order Sets 30-Day Deadline for Drugmakers to Lower Prices
(MedPage Today) -- President Trump on Monday signed a sweeping executive order setting a 30-day deadline for drugmakers to lower the cost of prescription drugs in the U.S.
Read MoreTrump Signs Executive Order Asking Companies to Lower Drug Prices
The president has long complained that the United States pays more for medicines than other wealthy countries. But he offered no clear legal authority to mandate lower prices.
Read MoreSTAT+: UnitedHealth’s financial miscues, and an $800 million revenue cycle bonanza
In this week's Health Care Inc. newsletter, UnitedHealth’s financial miscues, an $800 million revenue cycle bonanza, and much more.
Read MoreDo you feel proud when you succeed – or just relieved?
If you don’t appreciate your success when completing a tough project, these tips can change the way you thinkEvery time I complete a professional project, the dominant emotion I feel is relief – r
Read MoreTrump's Surgeon General Pick Questions Vaccines, Touts Organics, Talks Spirituality
(MedPage Today) -- President Trump's newest surgeon general nominee is a burgeoning health influencer who has shared her approach to healthcare through appearances on some of the nation's most popula
Read MoreMarginal Benefits in High-Risk Ovarian Cancer With Addition of Bevacizumab to Chemo
(MedPage Today) -- Patients with high-risk advanced ovarian cancer obtained a marginal survival benefit with the addition of bevacizumab (Avastin) to first-line chemotherapy, while patients without h
Read MoreOne Immunosuppressant Superior for Preventing Nephrotic Syndrome Relapse in Kids
(MedPage Today) -- Tacrolimus outshined another immunosuppressive drug at extending relapse-free survival in kids with frequently relapsing or steroid-dependent nephrotic syndrome in a randomized stu
Read MoreBiomarker Points to Anti-Inflammatory Action of Sparsentan
(MedPage Today) -- Early findings from the SPARTAN phase II trial, presented at the National Kidney Foundation (NKF) Spring Clinical Meeting, suggested that benefits with sparsentan (Filspari) for im
Read More